DiscoverThe ExecutiveEmbracing Ambiguity: Dr. Seth Lederman, CEO & Chairman of Tonix Pharmaceuticals
Embracing Ambiguity: Dr. Seth Lederman, CEO & Chairman of Tonix Pharmaceuticals

Embracing Ambiguity: Dr. Seth Lederman, CEO & Chairman of Tonix Pharmaceuticals

Update: 2024-03-22
Share

Description

Dr. Seth Lederman, CEO and Chairman of Tonix Pharmaceuticals, shares insights into his journey from medical practice to pharmaceutical entrepreneurship. From his early days combating the AIDS epidemic to specializing in rheumatology and fibromyalgia research, Dr. Lederman discusses the lessons learned from founding and leading Tonix Pharmaceuticals.



Dr. Lederman offers valuable insights into the dynamics of drug development and commercialization. He also shares his perspective as a seasoned CEO, providing actionable advice on effective leadership and fostering a culture of innovation within the company. With the impending launch of Tanmaya, Tonix's pioneering product for fibromyalgia management, Dr. Lederman highlights the company's mission to address unmet medical needs and enhance patient well-being.

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Embracing Ambiguity: Dr. Seth Lederman, CEO & Chairman of Tonix Pharmaceuticals

Embracing Ambiguity: Dr. Seth Lederman, CEO & Chairman of Tonix Pharmaceuticals

Matt Harbert